These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Experimental and clinical experiences with staphylomycin against germs of the staphylococcus strain in a dermatologic hospital]. Rudat KD; Riebel-Schöpfel I; Rudat-Mrugowsky G Z Haut Geschlechtskr; 1967 Jun; 42(12):423-6. PubMed ID: 4232174 [No Abstract] [Full Text] [Related]
7. Eradication or decolonization of methicillin-resistant Staphylococcus aureus carriage: what are we doing and why are we doing it? Bradley SF Clin Infect Dis; 2007 Jan; 44(2):186-9. PubMed ID: 17173214 [No Abstract] [Full Text] [Related]
8. [Methicilline-sensitive and methicilline-resistant Staphylococcus aureus related morbidity in chronic wounds: a prospective study]. Trividic-Rumeau M; Bouyssou-Gauthier ML; Mounier M; Sparsa A; Blaise S; Bédane C; Bonnetblanc JM Ann Dermatol Venereol; 2003; 130(6-7):601-5. PubMed ID: 13679695 [TBL] [Abstract][Full Text] [Related]
9. Selection of methicillin-resistant Staphylococcus aureus following increased use of vancomycin despite restricted use of third generation cephem. Iwakawa K; Tsusaka N; Kizu J; Yamamoto K Jpn J Infect Dis; 1999 Oct; 52(5):221-2. PubMed ID: 10680092 [No Abstract] [Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help? Kluytmans J; Harbarth S Infect Control Hosp Epidemiol; 2009 Jul; 30(7):633-5. PubMed ID: 19496651 [No Abstract] [Full Text] [Related]
11. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus. De Gascun C; Rajan L; O'Neill E; Smyth EG J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085 [No Abstract] [Full Text] [Related]
12. Vancomycin levels, efficacy, and toxicity. Johnson JR Arch Intern Med; 2007 Jun; 167(11):1207; author reply 1208-9. PubMed ID: 17563035 [No Abstract] [Full Text] [Related]
13. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus? Hota B Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554 [No Abstract] [Full Text] [Related]
14. MRSA: when to suspect it, how to treat it. Lawrence KR; Golik MV; Davidson L Med Econ; 2008 Apr; 85(8):40-5. PubMed ID: 18499980 [No Abstract] [Full Text] [Related]
15. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Máiz L; Cantón R; Mir N; Baquero F; Escobar H Pediatr Pulmonol; 1998 Oct; 26(4):287-9. PubMed ID: 9811080 [No Abstract] [Full Text] [Related]
16. Bacteriology of leg ulcers. Ramelet AA; Perrenoud D Curr Probl Dermatol; 1999; 27():20-5. PubMed ID: 10547724 [No Abstract] [Full Text] [Related]
17. Comment on guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. Leibovici L; Paul M J Antimicrob Chemother; 2006 Jul; 58(1):220. PubMed ID: 16601065 [No Abstract] [Full Text] [Related]
18. Oral antibiotic treatment of MRSA infections. Cunha BA J Hosp Infect; 2005 May; 60(1):88-90. PubMed ID: 15823667 [No Abstract] [Full Text] [Related]
19. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections. Rahman M J Antimicrob Chemother; 1998 Mar; 41(3):325-8. PubMed ID: 9578158 [No Abstract] [Full Text] [Related]